Clinical trials in A Coruna Galicia – page 21

585 clinical trials in A Coruna Galicia, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in SpainEnsayosClinicos.es

A Coruna Galicia at a glance

585

clinical trials

Research sites3

Quick filters

585 trials in A Coruna Galicia

Open in trial search

Systemic scleroderma+1

Not yet recruiting

Study of CC-97540 (CD19‑Targeted NEX‑T CAR T) versus drug combination in adults with active systemic sclerosis

Registered drugNo placebo

Study of CC-97540 (CD19‑Targeted NEX‑T CAR T) versus drug combination in adults with active systemic sclerosis

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:CC-97540
Sponsor:Celgene Corp.

Contact Research Centre

Hepatocellular carcinoma+5

Not yet recruiting

DB-1311 in Combination with BNT327 or DB-1305 for Patients with Advanced or Metastatic Solid Tumors

InvestigationalNo placebo

DB-1311 in Combination with BNT327 or DB-1305 for Patients with Advanced or Metastatic Solid Tumors

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:BNT327
Sponsor:Dualitybio Inc.

Contact Research Centre

Pre-eclampsia

Not yet recruiting

Acetylsalicylic Acid for Preventing Preeclampsia in Pregnant Women

Registered drugNo placebo

Acetylsalicylic Acid for Preventing Preeclampsia in Pregnant Women

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Acetylsalicylic Acid
Sponsor:Fundacio Hospital Universitari Vall D’Hebron Institut De Recerca

Contact Research Centre

Partial seizures

Not yet recruiting

A study to evaluate the effectiveness and safety of vormatrigine in adults with focal epilepsy who are taking one to three anti-seizure medications.

Investigational

A study to evaluate the effectiveness and safety of vormatrigine in adults with focal epilepsy who are taking one to three anti-seizure medications.

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Vormatrigine
Sponsor:Praxis Precision Medicines Inc.

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

A study to evaluate the safety and effectiveness of petosemtamab and pembrolizumab in adults with non-small cell lung cancer

Registered drugNo placebo

A study to evaluate the safety and effectiveness of petosemtamab and pembrolizumab in adults with non-small cell lung cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:Merus B.V.

Contact Research Centre

Psoriatic arthropathy

Not yet recruiting

A study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis

Investigational

A study to evaluate the effectiveness and safety of JNJ-88545223 in people with active psoriatic arthritis

Investigational

Spain

Participants:18–64 years · 65+ years
Sponsor:Janssen Cilag International

Contact Research Centre

Acquired ATTR amyloidosis

Not yet recruiting

A Study of Acoramidis for Long-Term Safety in Patients with Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy

InvestigationalNo placebo

A Study of Acoramidis for Long-Term Safety in Patients with Newly Diagnosed Variant Transthyretin Amyloid Cardiomyopathy

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Acoramidis Hydrochloride
Sponsor:Eidos Therapeutics Inc.

Contact Research Centre

Immune thrombocytopenia

Not yet recruiting

Study on the Safety and Effectiveness of Budoprutug in Patients with Immune Thrombocytopenia

InvestigationalNo placebo

Study on the Safety and Effectiveness of Budoprutug in Patients with Immune Thrombocytopenia

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Budoprutug
Sponsor:Climb Bio Inc.

Contact Research Centre

Renal cell carcinoma+2

Not yet recruiting

Study on the Safety and Effectiveness of AL8326 for Patients with Small Cell Lung Cancer Needing Second-Line Treatment

InvestigationalNo placebo

Study on the Safety and Effectiveness of AL8326 for Patients with Small Cell Lung Cancer Needing Second-Line Treatment

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:AL8326
Sponsor:Advenchen Pharmaceuticals LLC

Contact Research Centre

Cytomegalovirus infection

Not yet recruiting

Study on Preventing Cytomegalovirus Infection in Stem Cell Transplant Patients Using Cytolytic T Lymphocytes

Registered drugNo placebo

Study on Preventing Cytomegalovirus Infection in Stem Cell Transplant Patients Using Cytolytic T Lymphocytes

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Sponsor:Instituto De Investigacion Marques De Valdecilla

Contact Research Centre

Breast cancer female

Not yet recruiting

Study of Atezolizumab, Pertuzumab, and Trastuzumab for Patients with HER2 Positive Early High-Risk and Locally Advanced Breast Cancer

Registered drugNo placebo

Study of Atezolizumab, Pertuzumab, and Trastuzumab for Patients with HER2 Positive Early High-Risk and Locally Advanced Breast Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Atezolizumab
Sponsor:Fondazione Michelangelo

Contact Research Centre

Non-small cell lung cancer

Not yet recruiting

Study to Compare Zongertinib with Standard Treatment for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

Registered drugNo placebo

Study to Compare Zongertinib with Standard Treatment for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Carboplatin
Sponsor:Boehringer Ingelheim Espana S.A.

Contact Research Centre

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in A Coruna Galicia

What the registry says about research in the country

01 Cardiovascular Research

Innovative clinical trials focusing on atherosclerotic cardiovascular disease prevention are currently underway. These studies aim to evaluate new therapeutic approaches for reducing major adverse cardiovascular events in high-risk patients.

Primary Prevention Studies
Cardiovascular Risk Management
Novel Therapeutic Approaches

The research emphasizes preventive strategies for patients at high risk of developing cardiovascular complications, including heart attacks, strokes, and conditions requiring urgent coronary procedures.

Back to Spain All countries